This animal study investigated the effects of melanotan-II (MT-II), a melanocortin receptor agonist, on sexual behaviors in female rats. Ovariectomized Long-Evans rats were hormonally primed with either estradiol benzoate (EB) and progesterone (P) or EB alone, then received intravenous MT-II at doses of 1 mg/kg and 3 mg/kg before paced
This study examined the effects of short-term oral micronized progesterone on the vascular benefits of transdermal estradiol in 17 premenopausal women. Participants underwent hormone suppression with a gonadotropin-releasing hormone antagonist for 10-12 days, followed by supplementation with either 200 mg oral micronized progesterone or 0.1 mg transdermal estradiol. The results
This observational study explores the impact of menopause on gut microbiome composition and diversity, highlighting how declining estrogen and progesterone levels lead to reduced microbial diversity and shifts in bacterial populations. Post-menopausal women exhibit lower levels of beneficial bacteria (e.g., Firmicutes, Ruminococcus) and increased potentially harmful bacteria (e.g., Prevotella, Bilophila),
A review published in Postgraduate Medicine examined the safety and efficacy of bioidentical hormones (progesterone, estradiol, and estriol) compared to synthetic and animal-derived hormones used in hormone replacement therapy (HRT). The study found that patients reported greater satisfaction with HRT containing bioidentical progesterone over synthetic progestins. Clinical and physiological data
This randomized, double-blind, placebo-controlled study evaluated the effects of 300 mg of oral progesterone administered nightly for three weeks on sleep architecture and hormonal profiles in healthy postmenopausal women. The results indicated that while progesterone did not affect undisturbed sleep, it significantly improved sleep disturbances caused by blood sampling, reducing
This study examines the neuroprotective effects of progesterone following cerebral ischemia and reperfusion injury in rats. The findings show that progesterone administration significantly preserves mitochondrial function and reduces neuronal apoptosis in the brain regions affected by ischemia. These results suggest that progesterone may offer therapeutic benefits for mitigating ischemic brain
This study investigates the neuroprotective effects of progesterone in a rat model of focal cerebral ischemia. The findings show that progesterone helps preserve mitochondrial function and reduce neuronal damage following reperfusion, suggesting that it could be a promising therapeutic option for mitigating stroke-related brain injury. By maintaining mitochondrial integrity and
This study investigates the neuroprotective effects of progesterone (P4) in a rat model of ischemic stroke induced by transient middle cerebral artery occlusion (tMCAO). The results demonstrate that P4 significantly reduces infarct volume, preserves mitochondrial function, and decreases oxidative stress by inhibiting the mitochondrial permeability transition pore (mPTP). P4 also
This phase 3, randomized controlled trial evaluated the effects of a combined 17β-estradiol and progesterone oral capsule (TX-001HR) on vasomotor symptoms (VMS), quality of life, and sleep in postmenopausal women. The study found that TX-001HR significantly reduced the frequency and severity of VMS, which was associated with improvements in quality
This study explores the relationship between nocturia and menopause, emphasizing how hormonal changes, particularly decreased estrogen and progesterone, contribute to increased nocturia symptoms in middle-aged women. The review highlights that other factors, such as obesity, diabetes, and hypertension, also play significant roles in worsening symptoms. Management strategies like hormone replacement
